Relation Therapeutics
The Competitive & Portfolio Intelligence Lead at Relation is responsible for conducting comprehensive market analyses and competitive intelligence to assess external opportunities and optimize the internal pipeline value across various therapeutic areas. This role requires the synthesis of scientific, clinical, and commercial data, along with the development of financial models to inform strategic decision-making in partnership with R&D and leadership. The ideal candidate will have a background in life sciences and relevant experience in biotech, banking, or consulting, with strong analytical and communication skills to present insights to senior stakeholders.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2019
Relation Therapeutics is an innovative biotech company dedicated to transforming drug development by leveraging advanced technologies, including single-cell multi-omics and machine learning. Founded in 2020, Relation aims to deepen the understanding of human biology to discover therapies for some of the most challenging diseases. Their interdisciplinary team of experts is focused on developing high-resolution biology-driven medicines, with a clear commitment to addressing urgent medical needs. Based in London, Relation continues to forge strategic partnerships to enhance its therapeutic pipeline.
Mintz Advises Relation Therapeutics on Additional Funding Round, Including Strategic Investment from Novartis
Dec 9, 2025
Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Dec 9, 2025
Lab-in-a-loop specialist Relation attracts Novartis alliance
Dec 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Relation Therapeutics.
Relation Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Exclusive: Relation, Deerfield agree to form new companies from discovered drug targets
Jan 7, 2026
Manager, Competitive Intelligence
Legend Biotech
Science Manager for Biopharma Processing Aids Venture, Lyngby
Novonesis
Director of Corporate Strategy
argenx
Associate Director, Competitive Intelligence
Travere Therapeutics
Senior Manager, Competitive Intelligence
Nuvalent, Inc.
Intern, Competitive Intelligence
avidbio